Wednesday, 23 October 2013
Swiss Hospital Tests New Cancer Tool Developed by IBM Scientists
Posted on 00:22 by Unknown
IBM scientists are partnering with pathologists in Zurich, Switzerland to help unravel tumors and to assist in personalized treatment strategies.
Tissue staining is widely used in pathology to detect disease markers in
a patient's sample. More specifically, a particular disease marker is
bound with an antibody, which is then chemically colored or stained on
the tissue. The intensity of the
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment